Cathy Coppinger recently stepped down as manager of the NHS sickle cell and thalassaemia (SCT) screening programme to enjoy a well-deserved retirement. Her former colleagues pay tribute to her hard work.
Jamili Miah joined Public Health England in September 2013. Jamili worked for the Diabetic Eye Screening Programme in Birmingham for three years as a screener and disease grader. She then moved to London to join the NHS Newborn Blood Spot Screening Programme Team as Project Support. Her work has included supporting the national roll out of expanded screening and, implementing the new blood spot quality guidelines across all English newborn screening laboratories. In addition Jamili has recently also joined the Sickle Cell and Thalassaemia Screening Programme.
We are working with the Sickle Cell Society to update the Sickle Cell Disease in Childhood: Standards and guidelines for clinical care. We want you to tell us your views.
Early access to sickle cell and thalassaemia screening is important in giving time to women and couples to consider their options. Performance varies across the country, so we are sharing some best practice tips and a new checklist tool.
We are working with the Sickle Cell Society to update the Sickle Cell Disease in Childhood: Standards and guidelines for clinical care 2nd edition. Please let us know what you think of the clinical care standards.
The NHS Sickle Cell and Thalassaemia Screening Programme is excited to offer 25 funded places on the King’s College London Genetic Risk Assessment and Counselling course. This year the 4-day course takes place on 9 May, 10 May, 13 June and 14 June 2019.
Details of the February 2019 changes and improvements to the sickle cell and thalassaemia screening family origin questionnaire.
We have updated our national guidance on counselling and referral for prenatal diagnosis for women and couples at risk of having a baby with sickle cell disease or thalassaemia major.
Newborn blood spot screening is a recommended routine part of the screening pathway for babies in England. The NHS Newborn Blood Spot Screening Programme (also known as the heel prick test) screens newborn babies for 9 rare but serious conditions. Babies …
We, the sickle cell and thalassaemia (SCT) screening programme, are launching an exciting new project which aims to engage the public and service users. This will help improve how we deliver screening for sickle cell and thalassaemia.
It’s been a year since the NHS newborn blood spot screening programme expanded screening for an additional 4 inherited metabolic diseases (IMDs): maple syrup urine disease (MSUD) isovaleric acidaemia (IVA) glutaric aciduria type 1 (GA1) homocystinuria (pyridoxine unresponsive) (HCU) We …